HC Wainwright & Co. Reiterates Buy on Genprex, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Genprex (NASDAQ:GNPX) and maintained a $10 price target.
April 04, 2024 | 10:33 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Genprex maintains a Buy rating and a $10 price target from HC Wainwright & Co., indicating a positive outlook on the stock.
The reiteration of a Buy rating and a maintained price target of $10 by a reputable analyst firm like HC Wainwright & Co. suggests a strong confidence in Genprex's potential for growth. This positive outlook is likely to influence investor sentiment and could lead to a short-term increase in GNPX's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100